top of page
  • Autorenbild-

ONCOBONE VENTURES AND ORIGENIS ANNOUNCE PARTNERSHIP TO DEVELOP NOVEL THERAPIES FOR CANCER BONE METASTASIS

London, UK – OncoBone Ventures Ltd, based in the UK, and Origenis GmbH, headquartered in Planegg, Germany, have signed a Framework Agreement to develop novel therapies targeJng cancer bone metastasis, addressing a significant unmet medical need. Currently, there are no effecJve treatments for bone metastases, which affect 70-90% of advanced breast and prostate cancer paJents, with less than 5% surviving beyond five years post-diagnosis.


Press release Origenis OncoBone
.pdf
PDF herunterladen • 104KB

309 Ansichten

Comments


Commenting has been turned off.
bottom of page